Endokrin Bozukluklar ve İnfertilite İlişkisi
Özet
Sağlanan bilimsel metin, üreme sistemi ve endokrin bozukluklar arasındaki karmaşık ve doğrudan ilişkiyi incelemektedir. Hipofizer-Pitüiter-Over (HPO) döngüsü, ovulasyon ve uterus fonksiyonları açısından kritik öneme sahip olup; tiroid ve böbrek üstü bezleri gibi diğer endokrin organlardaki bozukluklar jinekolojik problemlere ve infertiliteye yol açmaktadır. Makalede, kadın infertilitesinin fonksiyonel hipotalamik amenore, aşırı egzersiz, stres ve beslenme eksikliği gibi hipotalamik nedenleri detaylandırılmaktadır. Ayrıca, üremeyi olumsuz etkileyen hipofiz bozukluklarından hiperprolaktinemi ve akromegali; adrenal bozukluklardan Cushing sendromu, konjenital adrenal hiperplazi (KAH) ve Addison hastalığı ele alınmaktadır. Üreme çağındaki kadınlarda sıkça görülen tiroid hastalıklarından hipotiroidizm ve hipertiroidizmin, hormonal dengeleri ve seks hormonu bağlayıcı globulin (SHBG) düzeylerini değiştirerek infertilite riskini artırdığı belirtilmektedir. Ovaryan fonksiyon bozuklukları kapsamında ise Polikistik Over Sendromu (PKOS) ve bunun neden olduğu anovulasyon ile insülin direnci süreçleri incelenmektedir. Sonuç olarak, infertilite şikayetiyle başvuran hastaların tanı sürecinde kapsamlı bir tıbbi geçmiş, fizik muayene ve prolaktin, TSH, FSH, E2 gibi laboratuvar testleriyle endokrin bozukluklar açısından bütüncül değerlendirilmesi gerektiği vurgulanmaktadır.
The provided scientific text examines the complex and direct relationship between the reproductive system and endocrine disorders. The Hypophysial-Pituitary-Ovarian (HPO) axis is of critical importance for ovulation and uterine functions; disorders in other endocrine organs, such as the thyroid and adrenal glands, lead to gynecological problems and infertility. The article details the hypothalamic causes of female infertility, such as functional hypothalamic amenore, excessive exercise, stress, and nutritional deficiencies. Furthermore, pituitary disorders that negatively affect reproduction, including hyperprolactinemia and acromegaly, as well as adrenal disorders like Cushing's syndrome, congenital adrenal hyperplasia (CAH), and Addison's disease, are discussed. It is stated that thyroid diseases, such as hypothyroidism and hyperthyroidism, which are frequently observed in women of reproductive age, increase the risk of infertility by altering hormonal balances and sex hormone-binding globulin (SHBG) levels. Within the scope of ovarian dysfunctions, Polycystic Ovary Syndrome (PCOS) and the associated processes of anovulation and insulin resistance are analyzed. In conclusion, it is emphasized that patients presenting with infertility complaints must be comprehensively evaluated for endocrine disorders during the diagnostic process through a detailed medical history, physical examination, and laboratory tests including prolactin, TSH, FSH, and E2 levels.
Referanslar
Gordon CM. Functional hypothalamic amenorrhea. New England Journal of Medicine. 2010; 263: 365–371.
Caronia LM, Martin C, Welt CK et al. A genetic basis for functional hypothalamic amenorrhea. New England Journal of Medicine. 2011; 364: 215–225.
Melmed S, Casanueva F, Hoffman A et al. Diagnosis and treatment of hyperprolactinemia: an endocrine society clinical practice guideline. Journal of Clinical Endocrinology & Metabolism. 2011; 96: 273–288.
Unuane, D., Tournaye, H., Velkeniers, B., & Poppe, K. Endocrine disorders & female infertility. Best Practice & Research Clinical Endocrinology & Metabolism. 2011; 25(6): 861-873.
Yılmazer M. Hiperprolaktinemi. Çiçek MN, Akyürek C, Çelik Ç, Haberal A (eds.) Kadın Hastalıkları ve Doğum Bilgisi içinde. Ankara: Atlas Kitapçılık; 2012. p. 1731-1744.
Chang AY, Auchus RJ. Endocrine disturbances affecting reproduction. Straus JF, Barbıerı RL, Gargiulo AR (eds.) Yen and Jaffe's Reproductive Endocrinology. 8nd ed. Philadelphia: Elsevier; 2019. p. 594-608.
Boyar Hİ. Kadın infertilitesi ve endokrinolojik hastalıklar. Dicle Tıp Dergisi. 2013;40(4):700-703.
Bergh T, Skarin G, Nillius SJ et al. Pulsatile GnRH therapy d an alternative successful therapy for induction of ovulation in infertile normo- and hyperprolactinaemic amenorrhoeic women with pituitary tumours. Acta Endocrinologica. 1985; 110:440–444.
Berezin M, Shimon I, Hadani M: Prolactinoma in 53 men: clinical characteristics and modes of treatment (male prolactinoma). Journal of Endocrinological Investigation. 1995; 18(6):436–441.
Molitch ME, Elton RL, Blackwell RE, et al: Bromocriptine as primary therapy for prolactin-secreting macroadenomas: results of a prospective multicenter study. The Journal of Clinical Endocrinology& Metabolism. 1985;60(4):698–705.
Webster J, Pisctelli G, Polli A et al. A comparison of cabergoline and bromocriptine in the treatment of hyperprolactinemic amenorrhea. Cabergoline comparative study group. New England Journal of Medicine. 1994; 33: 904–909.
Demir M, Yılmaz B. Endokrin Hastalıklar ve İnfertilite. Çiçek MN, Kahyaoğlu İ (eds.) Jinekolojik Endokrinoloji ve İnfertilite El Kitabı içinde. Modern Tıp Kitabevi; 2019.p. 445-460.
Kaltsas GA, Mukherjee JJ, Jenkins PJ et al. Menstrual irregularity in women with acromegaly. Journal of Clinical Endocrinology & Metabolism. 1999; 84: 2731–2735.
Chapman IM, Hartman ML, Straume M, et al. Enhanced sensitivity growth hormone (GH) chemiluminescence assay reveals lower postglucose nadir GH concentrations in men than women. The Journal of Clinical Endocrinology& Metabolism 1994; 78(6):1312–1319.
Newell-Price J, Bertagna X, Grossman AB, et al. Cushing’s syndrome. Lancet. 2006; 367(9522):1605–1617.
Hagenfeldt K, Janson PO, Holmdahl G et al. Fertility and pregnancy outcome in women with congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Human Reproduction. 2008; 23: 1607–1613.
Merke DP. Approach to the Adult with congenital adrenal hyperplasia due to 21-Hydroxylase deficiency. The Journal of Clinical Endocrinology& Metabolism. 2008; 93: 653–660.
Poppe K, Velkeniers B. Female infertility and the thyroid. Best Practice & Research Clinical Endocrinology & Metabolism. 2004;18:153–165.
Çalıkoğlu İ, Yazıcı G, Aykal G, Taşdelen B. Kadın infertilitesinde Tiroid Stimülan Hormon-Anti Müllerian hormon ilişkisi. Mersin Üniversitesi Sağlık Bilimleri Dergisi. 2019; 12(2): 284-292.
Krassas GE, Poppe K, Glinoer D: Thyroid function and human reproductive health. Endocrine Reviews. 2010; 31(5):702–755.
Demirci N, Coşuner Potur D.İnfertilitede Temel Kavramlar, Etyolojisi ve Risk Faktörleri. Demirci N, Kızılkaya Beji N (eds). İnfertilite Hemşireliği El Kitabı içinde. İstanbul; 2017. p. 11-36.
Legro RS. Pregnancy considerations in women with poly-cystic ovary syndrome. Clinical Obstetrics and Gynecology. 2007;50: 295- 304.
